There were 767 press releases posted in the last 24 hours and 173,002 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Immunitor initiates Phase II trial of oral immunotherapy vaccine to treat glioblastoma brain cancer

TO:
Aldar Bourinbaiar
Immunitor Inc
+1 301-476-0930

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image